Drugs / FES
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05088785 | Oct 2021 → Dec 2026 expected | breast cancer | Amsterdam UMC, location VUmc | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FES | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05088785 ↗ |